Episurf Medical Future Growth

Future criteria checks 2/6

Episurf Medical is forecast to grow earnings and revenue by 5.1% and 68.2% per annum respectively. EPS is expected to grow by 41.4% per annum. Return on equity is forecast to be -129.2% in 3 years.

Key information

5.1%

Earnings growth rate

41.4%

EPS growth rate

Medical Equipment earnings growth	22.8%
Revenue growth rate	68.2%
Future return on equity	-129.2%
Analyst coverage	Low
Last updated	16 Jul 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:EPISBS - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	60	-74	-79	-73	1
12/31/2025	28	-78	-82	-77	1
12/31/2024	14	-81	-81	-75	1
6/30/2024	12	-85	-92	-84	N/A
3/31/2024	11	-92	-93	-85	N/A
12/31/2023	10	-95	-94	-85	N/A
9/30/2023	4	-97	-96	-85	N/A
6/30/2023	2	-94	-88	-77	N/A
3/31/2023	5	-84	-85	-74	N/A
12/31/2022	7	-77	-81	-69	N/A
9/30/2022	14	-72	-74	-63	N/A
6/30/2022	12	-71	-72	-62	N/A
3/31/2022	9	-69	-70	-61	N/A
12/31/2021	7	-69	-67	-60	N/A
9/30/2021	7	-67	-63	-58	N/A
6/30/2021	7	-66	-61	-56	N/A
3/31/2021	5	-63	-60	-55	N/A
12/31/2020	5	-64	-59	-54	N/A
9/30/2020	5	-66	-63	-58	N/A
6/30/2020	5	-69	-63	-59	N/A
3/31/2020	5	-73	-66	-61	N/A
12/31/2019	5	-70	-65	-59	N/A
9/30/2019	5	-66	-62	-55	N/A
6/30/2019	5	-62	-69	-61	N/A
3/31/2019	4	-59	-62	-54	N/A
12/31/2018	4	-58	-62	-52	N/A
9/30/2018	4	-58	-64	-55	N/A
6/30/2018	3	-59	-58	-49	N/A
3/31/2018	3	-55	N/A	-62	N/A
12/31/2017	3	-61	N/A	-61	N/A
9/30/2017	3	-64	N/A	-59	N/A
6/30/2017	2	-65	N/A	-59	N/A
3/31/2017	2	-69	N/A	-53	N/A
12/31/2016	2	-62	N/A	-56	N/A
9/30/2016	7	-57	N/A	-55	N/A
6/30/2016	8	-53	N/A	-50	N/A
3/31/2016	7	-48	N/A	-44	N/A
12/31/2015	7	-44	N/A	-38	N/A
9/30/2015	2	-38	N/A	-34	N/A
6/30/2015	2	-34	N/A	-34	N/A
3/31/2015	2	-32	N/A	-30	N/A
12/31/2014	2	-33	N/A	-32	N/A
9/30/2014	3	-31	N/A	-31	N/A
6/30/2014	2	-28	N/A	-31	N/A
3/31/2014	2	-26	N/A	-25	N/A
12/31/2013	2	-23	N/A	-21	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EPISBS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: EPISBS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: EPISBS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: EPISBS's revenue (68.2% per year) is forecast to grow faster than the UK market (3.7% per year).

High Growth Revenue: EPISBS's revenue (68.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EPISBS is forecast to be unprofitable in 3 years.